Implants News and Research

RSS

$University of Oregon physicist to design fractal vision devices$

University of Oregon physicist to design fractal vision devices

University of Oregon researcher Richard Taylor is on a quest to grow flowers that will help people who've lost their sight, such as those suffering from macular degeneration, to see again.

6 May 2011

BSX announces international launch and first implant of new cardiac devices

Boston Scientific Corporation today announced the launch and first implants of its ENERGEN and PUNCTUA cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators in Europe and other international markets.

6 May 2011

Keller Medical's silicone breast implant delivery device receives European CE Mark approval

Keller Medical, Inc., a privately held company, announced today that it has received CE approval for the Keller Funnel gel implant delivery device.

6 May 2011

Caldera's Desara Mini implant for Stress Urinary Incontinence receives CE Mark certification

Caldera Medical today announced that it has achieved CE Mark certification for its Desara Mini implant, an extension of its popular Desara brand for the treatment of Stress Urinary Incontinence.

6 May 2011

Symmetry Medical first quarter revenue increases 13.4% to $95.8 million

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2011 financial results for the period ended April 2, 2011.

5 May 2011

MiMedx introduces AmnioFix Nerve Wrap for use in surgical procedures

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today the launch of AmnioFix Nerve Wrap, the Company's latest biologic implant processed to offer surgical and healing options for nerve repair.

5 May 2011

Artimplant reports net revenue of SEK 5.4 million for January - March, 2011

Artimplant AB: January 1 - March 31, 2011: Net revenue amounted to SEK 5.4 million.

4 May 2011

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.

4 May 2011

First implantation of WiCS wireless cardiac pacing system performed in Germany

EBR Systems, Inc., a privately held clinical stage company, announced today the first human implants of the WiCS Wireless Cardiac Stimulation System.

3 May 2011

Retina Implant's second clinical trial initial findings presented at ARVO 2011

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial.

3 May 2011

U.Va, Coulter Foundation partner for translational research in biomedical engineering

The University of Virginia and the Wallace H. Coulter Foundation have teamed to create a $20 million endowment to foster research collaboration between biomedical engineers and clinicians, with the goal of developing new technologies to improve patient care and human health.

3 May 2011

Diabetes cell implant company approved for Argentina clinical trial

Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.

3 May 2011

Zimmer launches UniWallis Posterior Dynamic Stabilization System in Europe and Asia Pacific

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced the launch of the next generation of its Wallis® Posterior Dynamic Stabilization System, the UniWallis™ System, in Europe and Asia Pacific. Since the debut of the Wallis System in 2000, feedback collected from surgeons revealed the need for a device that maintains all of the clinical advantages of the Wallis System, provides improved ease of use and offers a more anatomy-sparing procedure.

29 Apr 2011

Early diagnostic tool for joint replacement implant failure

A new test shows promise for detecting the early stages of a major cause of failure in joint replacement implants, so that patients can be treated and perhaps avoid additional surgery. More than 1.5 million total joint replacement operations are performed worldwide each year. While the success rate is 90 per cent, almost 10 per cent of implants fail and require additional surgery, report appears in the ACS journal Molecular Pharmaceutics.

28 Apr 2011

Advanced Orthopaedics & Spine Medicine to participate in iUni G2 knee implant trial

Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Performance Orthopedics to participate in iUni G2 knee implant trial

Dr. Gregory Martin of Performance Orthopedics of the Palm Beaches is participating in a ten year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Synthes, JNJ sign merger agreement for orthopaedics business

Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.

27 Apr 2011

Implants News and Research

University of Oregon physicist to design fractal vision devices

BSX announces international launch and first implant of new cardiac devices

Keller Medical's silicone breast implant delivery device receives European CE Mark approval

Caldera's Desara Mini implant for Stress Urinary Incontinence receives CE Mark certification

Symmetry Medical first quarter revenue increases 13.4% to $95.8 million

MiMedx introduces AmnioFix Nerve Wrap for use in surgical procedures

Artimplant reports net revenue of SEK 5.4 million for January - March, 2011

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

First implantation of WiCS wireless cardiac pacing system performed in Germany

Retina Implant's second clinical trial initial findings presented at ARVO 2011

U.Va, Coulter Foundation partner for translational research in biomedical engineering

Diabetes cell implant company approved for Argentina clinical trial

Zimmer launches UniWallis Posterior Dynamic Stabilization System in Europe and Asia Pacific

Early diagnostic tool for joint replacement implant failure

Advanced Orthopaedics & Spine Medicine to participate in iUni G2 knee implant trial

Performance Orthopedics to participate in iUni G2 knee implant trial

Synthes, JNJ sign merger agreement for orthopaedics business

Brookside Surgery Center to participate in iUni G2 knee implant trial

FDA clears Biomet's Active Articulation Hip System

Vexim's SpineJack implant obtains ISO certification in Canada

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News